Literature DB >> 23541598

Hydroa vacciniforme-like cutaneous T-cell lymphoma: clinicopathologic and immunohistochemical study of 12 cases.

Martin Sangueza1, Jose Antonio Plaza.   

Abstract

BACKGROUND: Hydroa vacciniforme (HV)-like lymphoma (HVL) is a rare and aggressive cutaneous T-cell lymphoma occurring mainly in children in Latin America and Asia. Chronic latent Epstein-Barr virus infection has been associated with both HV and HVL.
OBJECTIVE: We sought to evaluate the clinical presentation and histopathology of this rare cutaneous T-cell lymphoma.
METHODS: We reviewed the clinical, morphologic, and immunophenotypical features in 12 cases of HVL from Bolivia.
RESULTS: All 12 patients had skin lesions in both sun-exposed and nonsun-exposed areas, including edema, blistering, ulceration, and scarring, with a slowly progressive relapsing course. All 12 patients presented with systemic symptoms and showed a characteristic swelling of the nose and lips, and periorbital edema. Eight patients died an average of 5.3 months after initial diagnosis. Four patients remained alive with persistent disease. Histopathologic examination showed an atypical lymphocytic infiltrate with angiotropism and angiocentricity. The immunophenotype showed a cytotoxic T-cell (CD8(+)) profile. All cases were associated with Epstein-Barr virus infection and differed clinically from other forms of cutaneous T-cell lymphoma. LIMITATIONS: Only a limited number of cases were studied.
CONCLUSIONS: This study confirms that HVL is a highly aggressive lymphoma, although some patients have a more indolent, chronic course.
Copyright © 2013 American Academy of Dermatology, Inc. Published by Mosby, Inc. All rights reserved.

Entities:  

Mesh:

Year:  2013        PMID: 23541598     DOI: 10.1016/j.jaad.2013.01.037

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN: 0190-9622            Impact factor:   11.527


  10 in total

1.  Clinicopathological analysis of the hydroa vacciniforme-like lymphoproliferative disorder with natural killer cell phenotype compared with cutaneous natural killer T-cell lymphoma.

Authors:  Guan-Nan Wang; Yong Cui; Wu-Gan Zhao; Ling Li; Xu-Dong Zhang; Yu Chang; Xian-Zheng Gao; Ye Li; Ming-Zhi Zhang; Wen-Cai Li
Journal:  Exp Ther Med       Date:  2018-09-19       Impact factor: 2.447

2.  Hydroa vacciniforme-like lymphoproliferative disorder in Ecuadorian children: A case series.

Authors:  Eduardo Garzón; John Jairo Dávila-Rodríguez
Journal:  Indian J Dermatol Venereol Leprol       Date:  2021-04-12       Impact factor: 2.545

Review 3.  Systemic lymphoma arising from hydroa vacciniforme-like lymphoma: report of two cases with review of literature.

Authors:  Yu-Qiong Yang; Lei Fan; Li Wang; Ji Xu; Run Zhang; Zheng Ge; Jian-Yong Li; Wei Xu
Journal:  Int J Clin Exp Pathol       Date:  2014-08-15

Review 4.  The 2018 update of the WHO-EORTC classification for primary cutaneous lymphomas.

Authors:  Rein Willemze; Lorenzo Cerroni; Werner Kempf; Emilio Berti; Fabio Facchetti; Steven H Swerdlow; Elaine S Jaffe
Journal:  Blood       Date:  2019-01-11       Impact factor: 22.113

5.  A Case of Hydroa Vacciniforme-Like Lymphoproliferative Disorder Presenting As Orogenital Ulcerations.

Authors:  Yingyi Li; Yang Wang
Journal:  Ann Dermatol       Date:  2022-10       Impact factor: 0.722

Review 6.  New concepts in EBV-associated B, T, and NK cell lymphoproliferative disorders.

Authors:  Leticia Quintanilla-Martinez; Steven H Swerdlow; Thomas Tousseyn; Carlos Barrionuevo; Shigeo Nakamura; Elaine S Jaffe
Journal:  Virchows Arch       Date:  2022-10-11       Impact factor: 4.535

7.  Recurrent scarring papulovesicular lesions on sun-exposed skin in a 22-year-old man.

Authors:  Melissa A Levoska; Jeffrey I Cohen; Irini Manoli; Chyi-Chia Richard Lee; Steven S T Ching; Jessica Shand; Deborah Tamura; Kenneth H Kraemer; John J DiGiovanna
Journal:  J Am Acad Dermatol       Date:  2017-09-28       Impact factor: 11.527

8.  Atypical hydroa vacciniforme mimicking dermatomyositis: A case report in a Lebanese girl.

Authors:  Maya Hijazi; Joelle Malek; Mona Nabulsi; Samer Ghosn
Journal:  JAAD Case Rep       Date:  2015-02-06

Review 9.  EBV-Positive Lymphoproliferations of B- T- and NK-Cell Derivation in Non-Immunocompromised Hosts.

Authors:  Stefan D Dojcinov; Falko Fend; Leticia Quintanilla-Martinez
Journal:  Pathogens       Date:  2018-03-07

10.  Hydroa Vacciniforme-Like Lymphoproliferative Disorder in Korea: Prognostic Implication of Clinical Signs and Whole Blood Epstein-Barr Virus DNA.

Authors:  Se Jin Oh; Jongeun Lee; Ji-Hye Park; Jong Hee Lee; Junhun Cho; Young-Hyeh Ko; Dongyoun Lee
Journal:  Ann Dermatol       Date:  2021-05-04       Impact factor: 1.444

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.